LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Cytek Biosciences Inc

Suletud

SektorTervishoid

2.67

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

2.63

Max

2.67

Põhinäitajad

By Trading Economics

Sissetulek

-21M

-11M

Müük

-16M

41M

Aktsiakasum

-0.027

Kasumimarginaal

-27.503

Töötajad

648

EBITDA

-13M

-15M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+120.97% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

5. aug 2025

Turustatistika

By TradingEconomics

Turukapital

-110M

383M

Eelmine avamishind

2.67

Eelmine sulgemishind

2.67

Uudiste sentiment

By Acuity

50%

50%

173 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

Cytek Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. mai 2025, 19:39 UTC

Suurimad hinnamuutused turgudel

UroGen Falls to 52-Week Low, FDA Document Indicates Cancer Drug Study Disagreement

17. mai 2025, 09:30 UTC

Peamised uudised
Tulu

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

17. mai 2025, 08:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. mai 2025, 08:20 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

17. mai 2025, 05:30 UTC

Omandamised, ülevõtmised, äriostud

Tradeweb Is Looking to Come to a Bond Market Near You -- Barrons.com

16. mai 2025, 23:18 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

16. mai 2025, 22:30 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- Update

16. mai 2025, 21:56 UTC

Market Talk

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

16. mai 2025, 21:56 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. mai 2025, 21:54 UTC

Peamised uudised

U.S. Loses Last Triple-A Credit Rating -- WSJ

16. mai 2025, 21:22 UTC

Market Talk

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

16. mai 2025, 21:17 UTC

Market Talk

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

16. mai 2025, 21:17 UTC

Peamised uudised

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

16. mai 2025, 21:05 UTC

Market Talk

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

16. mai 2025, 20:55 UTC

Omandamised, ülevõtmised, äriostud

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. mai 2025, 20:50 UTC

Market Talk
Tulu

Financial Services Roundup: Market Talk

16. mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16. mai 2025, 20:37 UTC

Peamised uudised

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

16. mai 2025, 20:33 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

16. mai 2025, 20:30 UTC

Omandamised, ülevõtmised, äriostud

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

16. mai 2025, 20:18 UTC

Peamised uudised

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

16. mai 2025, 20:16 UTC

Peamised uudised

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

16. mai 2025, 20:15 UTC

Tulu

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

16. mai 2025, 20:11 UTC

Omandamised, ülevõtmised, äriostud

Henry Schein: William K. Daniel Joins Board

16. mai 2025, 20:10 UTC

Omandamised, ülevõtmised, äriostud

Henry Schein: Strategic Investment by KKR Completed

16. mai 2025, 20:05 UTC

Omandamised, ülevõtmised, äriostud

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

16. mai 2025, 19:38 UTC

Market Talk

Oil Futures Post Second Straight Weekly Gain -- Market Talk

16. mai 2025, 19:07 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

16. mai 2025, 18:51 UTC

Peamised uudised

Early Read on Consumer Sentiment Falls to Second Lowest on Record -- 5th Update

16. mai 2025, 18:41 UTC

Omandamised, ülevõtmised, äriostud

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Cytek Biosciences Inc Prognoos

Hinnasiht

By TipRanks

120.97% tõus

12 kuu keskmine prognoos

Keskmine 5.9 USD  120.97%

Kõrge 9 USD

Madal 4 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Cytek Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

5 ratings

2

Osta

2

Hoia

1

Müü

Tehniline skoor

By Trading Central

3.7 / 3.8Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

173 / 382 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.